# Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

> **NCT00772174** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 418 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone and Metformin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00772174
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 418 (ACTUAL)
- **Last updated:** 2010-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772174, "Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00772174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*